Skip to main content
Top
Published in: Japanese Journal of Ophthalmology 1/2022

01-01-2022 | Laser | Clinical Investigation

Imbalanced choroidal circulation in eyes with asymmetric dilated vortex vein

Authors: Kiriko Hirooka, Michiyuki Saito, Yui Yamashita, Yuki Hashimoto, Nobuhiro Terao, Hideki Koizumi, Kousuke Noda, Susumu Ishida

Published in: Japanese Journal of Ophthalmology | Issue 1/2022

Login to get access

Abstract

Purpose

Asymmetric dilated vortex vein (ADVV) observed in eyes with pachychoroid spectrum diseases is thought to be due to congestion of choroidal blood flow. The purpose of this study was to quantitatively investigate the blood flow velocity of ADVV using laser speckle flowgraphy (LSFG).

Study design

Retrospective case series.

Methods

This was a retrospective case series with 23 eyes of 18 patients with ADVV on en-face OCT. A pair of choroidal veins from ADVV side (defined as ADVV vein) and non-ADVV side (defined as non-ADVV vein) was selected in each eye under the following criteria: (i) equivalent proximity to the deviated watershed, (ii) does not overlap with retinal blood vessels in the en-face OCT image, (iii) has approximately the same blood vessel diameter. Rubber bands were placed on the selected choroidal veins on the LSFG color map. Mean blur rate (MBR) values of ADVV and non-ADVV veins were statistically compared.

Results

The average MBR was 10.11 ± 1.9 in the ADVV veins and 13.49 ± 6.2 in the non-ADVV veins, showing significantly lower values in the ADVV veins (P = 0.03). The blood vessel diameter of the ADVV was 10.26 ± 3.0 and in the non-ADVV veins, 10.63 ± 2.9 pixels; not significantly different (P = 0.66). The distance from the deviated watershed to the ADVV was 53.3 ± 24.8 and to the non-ADVV veins, 46.80 ± 20.3 pixels; not significantly different (P = 0.41).

Conclusion

In eyes with ADVV, the blood flow velocity in the ADVV veins was lower than in the non-ADVV veins, suggesting anatomical congestion of ADVV.
Appendix
Available only for authorised users
Literature
1.
go back to reference Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol. 1994;112:1057–62.CrossRef Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol. 1994;112:1057–62.CrossRef
2.
go back to reference Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009;29:1469–73.CrossRef Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009;29:1469–73.CrossRef
3.
go back to reference Hiroe T, Kishi S. Dilatation of asymmetric vortex vein in central serous chorioretinopathy. Ophthalmol Retina. 2018;2:152–61.CrossRef Hiroe T, Kishi S. Dilatation of asymmetric vortex vein in central serous chorioretinopathy. Ophthalmol Retina. 2018;2:152–61.CrossRef
4.
go back to reference Saito M, Saito W, Hashimoto Y, Yoshizawa C, Fujiya A, Noda K, et al. Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy. Br J Ophthalmol. 2013;97:775–80.CrossRef Saito M, Saito W, Hashimoto Y, Yoshizawa C, Fujiya A, Noda K, et al. Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy. Br J Ophthalmol. 2013;97:775–80.CrossRef
5.
go back to reference Saito M, Saito W, Hirooka K, Hashimoto Y, Mori S, Noda K, et al. Pulse waveform changes in macular choroidal hemodynamics with regression of acute central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2015;56:6515–22.CrossRef Saito M, Saito W, Hirooka K, Hashimoto Y, Mori S, Noda K, et al. Pulse waveform changes in macular choroidal hemodynamics with regression of acute central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2015;56:6515–22.CrossRef
6.
go back to reference Imanaga N, Terao N, Nakamine S, Tamashiro T, Wakugawa S, Sawaguchi K, et al. Scleral thickness in central serous chorioretinopathy. Ophthalmol Retina. 2021;5:285–91.CrossRef Imanaga N, Terao N, Nakamine S, Tamashiro T, Wakugawa S, Sawaguchi K, et al. Scleral thickness in central serous chorioretinopathy. Ophthalmol Retina. 2021;5:285–91.CrossRef
7.
go back to reference Terao N, Koizumi H, Kojima K, Kusada N, Nagata K, Yamagishi T, et al. Short axial length and hyperopic refractive error are risk factors of central serous chorioretinopathy. Br J Ophthalmol. 2020;104:1260–5.PubMed Terao N, Koizumi H, Kojima K, Kusada N, Nagata K, Yamagishi T, et al. Short axial length and hyperopic refractive error are risk factors of central serous chorioretinopathy. Br J Ophthalmol. 2020;104:1260–5.PubMed
8.
go back to reference Ersoz MG, Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients. Br J Ophthalmol. 2019;103:725–9.CrossRef Ersoz MG, Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients. Br J Ophthalmol. 2019;103:725–9.CrossRef
9.
go back to reference Cardillo Piccolino F, Lupidi M, Cagini C, Fruttini D, Nicolò M, et al. Choroidal vascular reactivity in central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2018;59:3897–905.CrossRef Cardillo Piccolino F, Lupidi M, Cagini C, Fruttini D, Nicolò M, et al. Choroidal vascular reactivity in central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2018;59:3897–905.CrossRef
10.
go back to reference Sun J, Tan J, Wang Z, Yang H, Zhu X, Li L. Effect of catecholamine on central serous chorioretinopathy. J Huazhong Univ Sci Technol Med Sci. 2003;23:313–6.CrossRef Sun J, Tan J, Wang Z, Yang H, Zhu X, Li L. Effect of catecholamine on central serous chorioretinopathy. J Huazhong Univ Sci Technol Med Sci. 2003;23:313–6.CrossRef
11.
go back to reference Islam QU, Hanif MK, Tareen S. Frequency of systemic risk factors in central serous chorioretinopathy. J Coll Phys Surg Pak. 2016;26:692–5. Islam QU, Hanif MK, Tareen S. Frequency of systemic risk factors in central serous chorioretinopathy. J Coll Phys Surg Pak. 2016;26:692–5.
12.
go back to reference Liu B, Deng T, Zhang J. Risk factors for central serous chorioretinopathy: a systematic review and meta-analysis. Retina. 2016;36:9–19.CrossRef Liu B, Deng T, Zhang J. Risk factors for central serous chorioretinopathy: a systematic review and meta-analysis. Retina. 2016;36:9–19.CrossRef
13.
go back to reference Venkatesh P, Gadia R, Tewari HK, Kumar D, Garg S. Prehypertension may be common in patients with central serous choroioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2006;244:1101–3.CrossRef Venkatesh P, Gadia R, Tewari HK, Kumar D, Garg S. Prehypertension may be common in patients with central serous choroioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2006;244:1101–3.CrossRef
14.
go back to reference Saito M, Noda K, Saito W, Hirooka K, Hashimoto Y, Ishida S. Increased choroidal blood flow and choroidal thickness in patients with hypertensive chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2020;258:233–40.CrossRef Saito M, Noda K, Saito W, Hirooka K, Hashimoto Y, Ishida S. Increased choroidal blood flow and choroidal thickness in patients with hypertensive chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2020;258:233–40.CrossRef
Metadata
Title
Imbalanced choroidal circulation in eyes with asymmetric dilated vortex vein
Authors
Kiriko Hirooka
Michiyuki Saito
Yui Yamashita
Yuki Hashimoto
Nobuhiro Terao
Hideki Koizumi
Kousuke Noda
Susumu Ishida
Publication date
01-01-2022
Publisher
Springer Japan
Keyword
Laser
Published in
Japanese Journal of Ophthalmology / Issue 1/2022
Print ISSN: 0021-5155
Electronic ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-021-00889-7

Other articles of this Issue 1/2022

Japanese Journal of Ophthalmology 1/2022 Go to the issue